Skip to main content

Peer Review reports

From: Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study

Original Submission
26 Sep 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
11 Nov 2021 Reviewed Reviewer Report
28 Nov 2021 Reviewed Reviewer Report
16 Dec 2021 Author responded Author comments - Guohai Su
Resubmission - Version 3
16 Dec 2021 Submitted Manuscript version 3
24 Dec 2021 Author responded Author comments - Guohai Su
Resubmission - Version 4
24 Dec 2021 Submitted Manuscript version 4
4 Jan 2022 Author responded Author comments - Guohai Su
Resubmission - Version 5
4 Jan 2022 Submitted Manuscript version 5
11 Jan 2022 Reviewed Reviewer Report
11 Jan 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
12 Jan 2022 Editorially accepted
25 Jun 2022 Article published 10.1186/s12872-022-02716-4

You can find further information about peer review here.

Back to article page